Drug eruption: A mimicker of Coronavirus disease-2019 rash
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infections can be associated with several cutaneous lesions, among which maculopapular rash is the most common. A maculopapular rash can also be induced by medications used for Coronavirus disease-2019 (COVID-19) treatment. The distinction...
Saved in:
Main Authors: | Tülin Ergun (Author), Ilkay Ergenç (Author), Seda Seven (Author), Dilek Seçkin (Author), Elif Cömert Özer (Author), Meryem Aktaş (Author), Elif Tükenmez Tigen (Author) |
---|---|
Format: | Book |
Published: |
Galenos Publishing House,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rash from the past: A case of recurrent reactive infectious mucocutaneous eruption triggered by common coronavirus
by: Jeffrey A. Lowell, MD, PhD, et al.
Published: (2024) -
Reticular skin eruption as the initial sign of coronavirus disease 2019 infection
by: Mark A. Strom, MD, et al.
Published: (2020) -
Psoriasiform rash following maculopapular eruption during the continued administration of pembrolizumab
by: Mayu Sato, et al.
Published: (2024) -
Desmoglein-1 Deficiency Mimicking Omenn Syndrome
by: Meltem Comert, et al.
Published: (2024) -
Pravastatin-Induced Eczematous Eruption Mimicking Psoriasis
by: Michael P. Salna, et al.
Published: (2017)